Market Access & Pricing
There are many barriers to accessing markets in the CEE: the high price of high-value medicines and low GDP per capita are just some of them. Medis knows how to operate successfully in these markets.
Our market access team has achieved more than 100 positive reimbursement decisions for high-value specialty and orphan drugs in the region.
Our success lies in our expertise and ability to collaborate with sales, marketing, and medical departments. We discover unmet market needs and then deliver the best products to meet them profitably.
We take a systematic, step-by-step approach to achieve positive reimbursement results:
- Building a comprehensive local access strategy
- Effectively communicating compelling value to stakeholders
- Aligning the global value dossier with country-specific submission documents
- Negotiating better pricing and reimbursement terms
- Ensuring accelerated approval and maintaining effective pricing and reimbursement solutions
Market access requires a combination of know-how, the ability to engage all relevant stakeholders, and experience in dealing with extremely challenging situations, while ensuring positive project outcomes and the continuation and improvement of existing services.Ivana StagličićHead of Market Access, Pricing and Reimbursement Medis Therapeutics
What our partners say about us
They have built a team with rhythm with collaboration at the very heart of everything they do. It’s a pleasure to work with such a great group of individuals who really understand what we do."
Marketing Lead MS IPM
Director, Strategic Business Partnerships Management (EMEA)
Director Sales Europe Third Party, Hospital Care Division
M stands for Motivated
E stands for Enthusiastic, Excellent, Enjoyable and Ethical
D stands for Dependable, Determinated and Delightful
I stands for Intelligent, Inspiring and Impeccable
S stands for Successful
I wish Medis all the best and to proceed further just as successfully."
Area Manager – East and South Europe
Regional Head of the Central/Eastern Europe and the CIS at Besins Healthcare, Russian Federation
Head of Established Brands, International Markets
I think we were growing scientifically together, because your colleagues were always coming back to us with difficult questions regarding product, substances, compositions, applications, that really helped us. Thirdly because of your great employees that are dedicated to our brand. We only wish to have partners like Medis in other countries! So wherever Medis is going in the future – you can count on us as well."
Founder of Pleuran
With Medis we have a long term partnership, a tradition and we respect that. Also it is great that one company has affiliates in different countries, so this model is most optimal for further collaboration for our Gengigel products."
Founder and President of company Ricerfarma